TECLISTAMAB for Plasma cell myeloma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 736 adverse event reports in the FDA FAERS database where TECLISTAMAB was used for Plasma cell myeloma.
Most Reported Side Effects for TECLISTAMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Cytokine release syndrome | 257 | 21.1% | 37 | 98 |
| Pneumonia | 101 | 8.3% | 39 | 83 |
| Plasma cell myeloma | 100 | 8.2% | 51 | 22 |
| Immune effector cell-associated neurotoxicity syndrome | 99 | 8.1% | 34 | 45 |
| Pyrexia | 86 | 7.0% | 25 | 52 |
| Covid-19 | 82 | 6.7% | 21 | 32 |
| Infection | 58 | 4.8% | 17 | 20 |
| Drug ineffective | 52 | 4.3% | 11 | 12 |
| Neutropenia | 48 | 3.9% | 7 | 15 |
| Sepsis | 48 | 3.9% | 36 | 41 |
| Febrile neutropenia | 44 | 3.6% | 5 | 38 |
| Death | 34 | 2.8% | 34 | 5 |
| Off label use | 34 | 2.8% | 11 | 11 |
| Covid-19 pneumonia | 31 | 2.5% | 6 | 31 |
| Diarrhoea | 28 | 2.3% | 4 | 11 |
Other Indications for TECLISTAMAB
Product used for unknown indication (251)
Plasma cell myeloma refractory (205)
Primary amyloidosis (6)
Other Drugs Used for Plasma cell myeloma
LENALIDOMIDE (273,951)
POMALIDOMIDE (81,096)
DEXAMETHASONE (49,067)
BORTEZOMIB (31,567)
DARATUMUMAB (19,119)
IXAZOMIB (17,602)
CARFILZOMIB (15,333)
THALIDOMIDE (10,689)
CYCLOPHOSPHAMIDE (9,148)
REVLIMID (7,122)